Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Food Effect of BBI-5000 in Healthy Adults
NCT02590289Phase 1Completed
- Sponsor
- Fresh Tracks Therapeutics
- Start
- Oct 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of BBI-5000 in atopic dermatitis (AD) (4 arms), sponsored by Fresh Tracks Therapeutics. Primary endpoints: Plasma concentrations of BBI-5000 and metabolites at Week 4, Area Under Curve at Week 4 and 6 more. Started Oct 2015; status: completed.
02
Drugs
BBI-5000
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02590289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02590289.